The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

Laura Fugazzola, Simone De Leo, Michela Perrino

Research output: Contribution to journalArticlepeer-review

Abstract

In the 9th ETA-CRN Meeting (September 2009, Lisbon) some recommendations from the American Thyroid Association (ATA) guidelines for the management of medullary thyroid cancer (MTC) were discussed by an European Panel of Experts (EPE). Among the 12 ATA recommendations related to hereditary MTC and to the optimal range of RET mutations to be tested (recommendations 1-5 and 9-15), 7 were shared and 5 were not shared by the EPE. In the present paper, the related comments and suggestions will be reported and discussed.

Original languageEnglish
Article numberS8
JournalThyroid Research
Volume6
Issue numberSUPPL.1
DOIs
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems
  • Endocrinology

Fingerprint Dive into the research topics of 'The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association'. Together they form a unique fingerprint.

Cite this